Primary Biliary Cirrhosis and Ankylosing Spondylitis, A Rare Association

1. C. L. Bowlus, M.E.Gershwin – The Diagnosis of Primary Biliary Cirrhosis, Autoimmunity Reviews, Volume 13, Issues 4 – 5, April – May 2014, pg.441 - 444.10.1016/j.autrev.2014.01.041398774524424173Open DOISearch in Google Scholar

2. S. C. Hauser, D. S. Pardi, J. J. Poterucha – Mayo Clinic Gastroenterology and Hepatology Board Review, Third Edition, Mayo Clinic Scientific Press And Informa Healthcare USA, Inc, 2008, Rochester, MN, pg.377-38110.1201/b14432Search in Google Scholar

3. K. D. Lindor,M. E. Gershwin, R. Poupon, M. Kaplan, N. V. Bergasa, and E. J. Heathcote – Primary biliary cirrhosis, AASLD Hepatology, AASLD Practice Guidelines, Volume 50, Issue 1, 2009, pg.291 – 308.10.1002/hep.2290619554543Search in Google Scholar

4. N. Bekki, S. K. Bae, S. Yoshizawa, A. Shiota, T. Gushima, J. Motoshita, S. Shimoda, Y. Aiba, A. Komori, M. Nakamura, K. Takahashi – A case of primary biliary cirrhosis in a patient with rheumatoid arthritis, Clinical Case Reports 2016; Volume 4, Issue 1, pg. 90–9410.1002/ccr3.449470641026783445Search in Google Scholar

5. S. Abraham, S. Begum, D. Isenberg – Hepatic manifestations of autoimmune rheumatic diseases, Annals of the Rheumatic Diseases, 2004, Volume 63, Issue 2, pg.123–129.10.1136/ard.2002.001826175490114722198Open DOISearch in Google Scholar

6. C. Caramella, J. Avouac, Ph. Sogni, X. Puéchal, A. Kahan, Y. Allanore – Case report: Association between rheumatoid arthritis and primary biliary cirrhosis, Joint Bone Spine 2007, 74(3), pg.279 – 28110.1016/j.jbspin.2006.06.01217369071Open DOISearch in Google Scholar

7. Reumatológia Jegyzet, Prof.Dr.Lia Georgescu, Litografia UMF Tirgu Mures, 2010, pg. 152 – 170Search in Google Scholar

8. S. Gonzaler-Roces, M. V. Alvarez,S. Gonzalez, A. Dieye, H. Makni, 0. G. Woodfield, L. Housan, V. Konenkov, M. C. Abbadi, N. Grunneta, E. Cotol, C. Lopez-tarreal - HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis, Tissue Antigens, Volume 49,Issue 2,1997, pg. 116–123.10.1111/j.1399-0039.1997.tb02724.x9062966Search in Google Scholar

9. C.A. Vargas, R. Medina, C.E. Rubio, E.A. Torres – Primary biliary cirrrhosis associated with Ankylosing spondylitis, Journal of Clinical Gastroenterology, 1994, 18(3), pg.263 – 264.10.1097/00004836-199404000-000328034941Open DOISearch in Google Scholar

10. J. Zochling, D. van der Heijde, R. Burgos-Vargas, E. Collantes, J. C. Davis Jr, B. Dijkmans, M. Dougados, P. Ge´her, R. D. Inman, M. A. Khan, T. K. Kvien, M. Leirisalo- Repo, I. Olivieri, K. Pavelka, J. Sieper, G. Stucki, R. D. Sturrock, S. van der Linden, D. Wendling, H. Bo¨hm, B. J. van Royen, J. Braun – ASAS/EULAR recommendations for themanagement of ankylosing spondylitis, Annals of the Rheumatic Diseases, 2006;65(4), pg:442 – 452.Search in Google Scholar

11. J. Braun, R. van den Berg, X. Baraliakos, H. Boehm, R. Burgos-Vargas, E. Collantes-Estevez, H. Dagfi nrud, B. Dijkmans, M. Dougados, P. Emery, P. Geher, M. Hammoudeh, R.D. Inman, M. Jongkees, M.A. Khan, U. Kiltz, T.K. Kvien, M. Leirisalo-Repo,W.P. Maksymowych, I. Olivieri, K. Pavelka, J. Sieper, E. Stanislawska-Biernat, D. Wendling, S. Özgocmen, C van Drogen, B.J. van Royen, D. van der Heijde - 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, 2011;Volume 70, Issue 6, pg.896 – 904.10.1136/ard.2011.151027308605221540199Search in Google Scholar

12. C.L. Kohema, A. B. Bortoluzzob, C. R. Gonçalvesc, J. A. Braga da Silvad, A. C. Ximenese, M. B. Bértolo f, S.L.E. Ribeirog, M. Keisermanh, R. Menini, T. L. Skarej, S. Carneirok, V. F. Azevedol, W. P. Vieiram, E. N. Albuquerquen, W. A. Bianchio, R. Bonfigliolip, C. Campanholoq, H. M. S. Carvalhor, I. Pereira da Costas, A. L. B. Pinto Duartet, N. H. Leiteu, S. A. L. Limaw, E. S. Meirellesx, I. A. Pereiray, M. M. Pinheiroz, E. Polito, G. G. Resende, F. A. C. Rocha, M. B. Santiago,M. de Fátima L. C. Sauma, V. Valim, P. D. Sampaio-Barros - Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides, Revista Brasileira de Reumatologia, 2013, 54(1), pg.33 – 37.10.1016/j.rbre.2014.02.004Search in Google Scholar

13. S. L. Taffet, K. M. Das – Sulfasalazine. Adverse effects desensitization, 1983, Volume 28, Issue 9, pg. 833 – 842.10.1007/BF012969076136396Search in Google Scholar

14. G. P. Aithal - Hepatotoxicity related to antirheumatic drugs, Nature Reviews Rheumatology, 2011, Volume 7, pg. 139 – 150.10.1038/nrrheum.2010.21421263458Open DOISearch in Google Scholar

15. A. Pandit, T. Sachdeva, P. Bafna – Drug – Induced Hepatotoxicity: A Review, Journal of Applied Pharmaceutical Science 2012, 02 (05); pg.233-24310.7324/JAPS.2012.2541Search in Google Scholar

16. P. Jobanputra, R. Amarasena, F. Maggs, D. Homer, S. Bowman, E. Rankin, A. Filer, K. Raza, R. Jubb - Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events, BMC Musculoskeletal Disorders 2008, 9:48.10.1186/1471-2474-9-48232963218405372Search in Google Scholar

17. R. Ionescu – Esenţialul în reumatologie, capitolul Spondilita anchilozantă, ed.Amaltea, Bucureşti, 2007, pg.281 – 292.Search in Google Scholar

18. Szekanecz Z. – Reumatológiai gyógyszeres terápia, EdituraMedicina, Budapesta, 2009, pg. 75 – 76.Search in Google Scholar